Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Femoroacetabular Impingement
Interventions: virtual doctor visit, Standard care doctor's visit; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Fracture; Pelvic, Insufficiency Fractures, Fragility Fracture, Sacroiliac; Fusion, Sacroiliac Joint Disruption, Sacroiliac Joint Dysfunction
Interventions: iFuse TORQ TNT Implant System; Device
Lead sponsor: SI-BONE, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Edina, Minnesota • Rochester, Minnesota • Wyomissing, Pennsylvania

Conditions: Arthropathy of Knee, Arthropathy of Hip, Lower Extremity Fracture, Orthopedic Disorder
Interventions: Daily Inspiratory Muscle Training (dIMT), Acute Inspiratory Muscle Training (aIMT), Standard of Care (SOC); Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Wear of Articular Bearing Surface of Prosthetic Joint, Hip Arthropathy
Interventions: polyethylene; Device
Lead sponsor: Osaka Metropolitan University; Other
Eligibility: 20 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Osteoarthritis, Hip, Avascular Necrosis of Hip
Interventions: One of the following hip implants may be used within this arm of the study: G7 Acetabular System, Taperloc Complete System, Avenir and Avenir Complete Systems, and Echo Bi-Metric System; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 2
States / cities: Jacksonville, Florida • Saint Joseph, Missouri

Conditions: Hip Osteoarthritis, Complications; Arthroplasty
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Arthropathy of Hip, Arthropathy of Knee
Interventions: Bupivacaine Only, EPI25, EPI50 group, EPI75 group, EPI100 group; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Knee Pain, Hip Pain, Ankle Pain, Lumbopelvic Pain
Interventions: lumbosacral joint manipulation, lumbar passive range of motion, No active intervention; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 50 Years
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Opioid Use, Opioid Dependence, Knee Pain Chronic, Knee Osteoarthritis
Interventions: Improved Opioid-Tapering Instructions, Clinical Patient Educator; Drug · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Low-back Pain, Hip Impairments, Hip-spine Syndrome, Osteoarthritis
Interventions: Hip-focused rehabilitation intervention, Spine-focused rehabilitation intervention; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 60 Years to 85 Years
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Newark, Delaware • Durham, North Carolina • Pittsburgh, Pennsylvania

Conditions: Chronic Hip Joint Pain, Prearthritic Hip Disease
Interventions: Rehabilitation; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 40 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: St Louis, Missouri • Pittsburgh, Pennsylvania

Conditions: Osteoarthritis, Hip, Blood Loss
Interventions: Werewolf Fastseal 6.0; Device
Lead sponsor: North Texas Medical Research Institute, PLLC; Other
Eligibility: 21 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Rockwall, Texas • Rowlett, Texas

Conditions: Osteoarthritis, Rheumatoid Arthritis, Avascular Necrosis
Interventions: Placebo, Lacosamide; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Arthropathy of Knee, Osteo Arthritis Knee, Osteonecrosis, Meditation, Knee Osteoarthritis, Knee Disease, Knee Injuries, Opioid Use, Opioid Dependence, Opioid Use Disorder
Interventions: Mindful meditation; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoarthritis, Hip, Rheumatoid Arthritis, Avascular Necrosis
Interventions: Not listed
Lead sponsor: Biomet Orthopedics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 4
States / cities: Chicago, Illinois • Pittsburgh, Pennsylvania • Fredericksburg, Virginia + 1 more

Conditions: Arthropathy of Knee, Arthropathy of Hip
Interventions: Supplementation with Nirvana Super Pro Liquid Supplements, Non-Supplementation Group; Dietary Supplement
Lead sponsor: Nirvana Water Sciences Corp; Industry
Eligibility: 45 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Altoona, Pennsylvania

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Fasinumab, Naproxen, Diclofenac, Celecoxib, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 6
States / cities: Phoenix, Arizona • Littleton, Colorado • Jacksonville, Florida + 3 more

Conditions: Osteoarthritis (OA) of the Hip, Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Shoulder, Osteoarthritis, Mild Cognitive Impairment, MCI, Mild Cognitive Impairment (MCI), Dementia
Interventions: Well-formulated ketogenic diet; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 55 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Fairway, Kansas

Conditions: Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip, Osteoarthritis, Hip, Osteoarthritis of Hip, Fractures, Hip, Fracture of Hip
Interventions: Vivacit-E and Longevity (HXLPE) Liners; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2033
U.S. locations: 6
States / cities: Denver, Colorado • South Bend, Indiana • Durham, North Carolina + 3 more

Conditions: Pain, Nausea, Vomiting
Interventions: CL-108; Drug
Lead sponsor: Charleston Laboratories, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Rheumatoid Arthritis, Osteoarthritis, Post-traumatic Arthritis, Avascular Necrosis
Interventions: Alumina/Alumina, Standard; Device
Lead sponsor: Encore Medical, L.P.; Industry
Eligibility: 18 Years and older
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2015
U.S. locations: 3
States / cities: Newport Beach, California • Charleston, South Carolina • Richmond, Virginia

Conditions: Rheumatoid Arthritis
Interventions: Not listed
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 90 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Pain
Interventions: Oxymorphone; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Hip
Interventions: FX006 32 mg; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 5
States / cities: Tucson, Arizona • Canoga Park, California • La Mesa, California + 2 more

Search by objective public record fields.

Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy

Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures

Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery

Polyethylene Wear Particle Analysis of THA

ROSA® Hip System THA PMCF

Correlation of Spinopelvic Parameters and Acetabular Cup Orientation

Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash

Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response

Can Simplified and More Detailed Instructions Affect Post-Operative Narcotic Consumption

Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain

Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders

Bipolar Sealer for Reduction of Blood Loss in Anterior Total Hip Arthroplasties

Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty:

Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement

A Clinical Investigation of the Balance® Microplasty™ Hip System

Nirvana Super Pro Supplementation in Orthopedic Surgery Patients

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Ketogenic Diet to Reduce Osteoarthritis Pain in MCI

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip

Cementless Alumina-Alumina Total Hip and Hybrid

Perioperative Flare in RA: Characterization of Clinical and Biological Features

A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip